Showing results (1481-1490 of 1,500) with videos related to

Sort By:
Pageof 150
NPJ Digital Medicine|February 5, 2025
Multiple large language models versus experienced physicians in diagnosing challenging cases with gastrointestinal symptomsXintian Yang, Tongxin Li, Han Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2024
PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2Chun-Liang Yang, Fa-Xi Wang, Jia-Hui Luo, et al.
Molecular Cancer|January 4, 2022
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trialTao Jiang, Jianhua Chen, Xingxiang Xu, et al.
Nature Communications|March 6, 2025
Retention of high-pressure solution-processable metastable phase to ambience via differential sublattice rigidity for broadband photodetectorsZhongyang Li, Jue Gong, Zhikai Zhu, et al.
Lancet (London, England)|May 29, 2026
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trialAnwen Xiong, Wenxiu Yao, Wei Zheng, et al.
Eclinicalmedicine|May 27, 2024
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 studyZhihao Lu, Li Kong, Buhai Wang, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|December 16, 2021
Effect of glucose metabolism disorders on the short-term prognosis in neonates with asphyxia: a multicenter study in Hubei Province, ChinaChun-Hua Liu, Hui Wang, Si-Cong Peng, et al.
Annals of the Rheumatic Diseases|May 19, 2019
T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritisXiao Liu, Wei Zhang, Ming Zhao, et al.
Advances in Therapy|September 4, 2024
Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III StudyYing Cheng, Zhanyu Pan, Lin Wu, et al.
Cell Research|November 18, 2017
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemiaLiang Huang, Dan Liu, Na Wang, et al.
Pageof 150